Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company opera... Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.042441 | -4.50378366218 | 0.942341 | 1.08 | 0.8009 | 34842 | 0.93138098 | CS |
| 4 | -0.3301 | -26.837398374 | 1.23 | 1.8 | 0.8009 | 129488 | 1.43602775 | CS |
| 12 | 0.1666 | 22.7192145098 | 0.7333 | 7.4899 | 0.672 | 2656932 | 2.61758105 | CS |
| 26 | -2.1801 | -70.7824675325 | 3.08 | 7.4899 | 0.46 | 1198228 | 2.59065607 | CS |
| 52 | -5.6101 | -86.1766513057 | 6.51 | 11.95 | 0.46 | 827602 | 3.90726173 | CS |
| 156 | -13.1001 | -93.5721428571 | 14 | 17.8 | 0.46 | 466960 | 5.84070681 | CS |
| 260 | -37.1001 | -97.6318421053 | 38 | 142.3 | 0.46 | 600246 | 17.53047504 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
